Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818764 · ClinicalTrials.gov registry record
Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 3
- Enrollment target
NCT02818764: Clinical Trial study, sponsored by University of Pennsylvania.
NCT02818764 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02818764 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The overall objective of this study is to test for perturbations in intraoperative electroencephalogram (EEG) , cerebral blood flow (CBF), cerebral metabolic rate of oxygen consumption (CMRO2), oxygen extraction fraction (OEF), and serum and cerebral spinal fluid biomarkers associated with delirium in high risk population having elective hip arthroplasty at Penn Presbyterian Medical Center (PPMC).
Interventions
- PROCEDURE Blood Draw
- PROCEDURE Cerebral Spinal Fluid collection
- DEVICE Electroencephalogram
- DEVICE Cerebral blood flow and oxygen extraction fraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02818764
The ClinicalTrials.gov registry entry for NCT02818764 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Blood Draw is the first listed.
NCT02818764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02818764 about?
NCT02818764 is a clinical study titled "Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty". The overall objective of this study is to test for perturbations in intraoperative electroencephalogram (EEG) , cerebral blood flow (CBF), cerebral metabolic rate of oxygen consumption (CMRO2), oxygen extraction fraction (OEF), and serum and cerebral spinal fluid biomarkers associated with delirium ...
What is the current status of trial NCT02818764?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2016-06. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02818764?
The interventions under investigation include: Blood Draw (PROCEDURE), Cerebral Spinal Fluid collection (PROCEDURE), Electroencephalogram (DEVICE), Cerebral blood flow and oxygen extraction fraction (DEVICE).
Who is sponsoring clinical trial NCT02818764?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.